Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Scheen

Showing results (561-570 of 595) with videos related to

Pageof 60
Sort By:
Revue Medicale De Liege|April 12, 2005
[Bariatric surgery: 10-year results of the Swedish Obese Subjects Study]A J Scheen, M Letiexhe, M Rorive, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 1, 1989
Effect of osmolality on availability of glucose ingested during prolonged exercise in humansB J Jandrain, F Pirnay, M Lacroix, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 11, 2009
Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17)A J Scheen, M H Tan, D J Betteridge, et al.
International Journal of Sports Medicine|October 1, 1995
Exogenous glucose oxidation during exercise in relation to the power outputF Pirnay, A J Scheen, J F Gautier, et al.
Revue Medicale De Liege|June 26, 1998
[Clinical case of the month. Galloping nephropathy in a patient with type 2 diabetes]J C Philips, A J Scheen, E Firre, et al.
Diabetes & Metabolism|November 7, 1998
Effects of gastroplasty on body weight and related biological abnormalities in morbid obesityF H Luyckx, A J Scheen, C Desaive, et al.
Revue Medicale De Liege|November 17, 2009
[Improved glucose control and weight loss with exenatide in patients with type 2 diabetes: results of a retrospective observational multicentre Belgian study]C De Block, N Paquot, N Daoudi, et al.
Revue Medicale De Liege|January 9, 2014
[European guidelines for the management of diabetes, prediabeties and cardiovascular disease. First part. Management of diabetes and cardiovascular risk factors]A J Scheen, R P Radermecker, J C Philips, et al.
Diabetologia|November 1, 1989
Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patientsA J Scheen, J Gillet, J Rosenthaler, et al.
Revue Medicale De Liege|May 13, 1999
[How I treat ... an individual with severe obesity and metabolic abnormalities with gastroplasty]F H Luyckx, A J Scheen, M R Letiexhe, et al.
Pageof 60

Showing results (561-570 of 595) with videos related to

Sort By:
Pageof 60
Revue Medicale De Liege|April 12, 2005
[Bariatric surgery: 10-year results of the Swedish Obese Subjects Study]A J Scheen, M Letiexhe, M Rorive, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 1, 1989
Effect of osmolality on availability of glucose ingested during prolonged exercise in humansB J Jandrain, F Pirnay, M Lacroix, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 11, 2009
Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17)A J Scheen, M H Tan, D J Betteridge, et al.
International Journal of Sports Medicine|October 1, 1995
Exogenous glucose oxidation during exercise in relation to the power outputF Pirnay, A J Scheen, J F Gautier, et al.
Revue Medicale De Liege|June 26, 1998
[Clinical case of the month. Galloping nephropathy in a patient with type 2 diabetes]J C Philips, A J Scheen, E Firre, et al.
Diabetes & Metabolism|November 7, 1998
Effects of gastroplasty on body weight and related biological abnormalities in morbid obesityF H Luyckx, A J Scheen, C Desaive, et al.
Revue Medicale De Liege|November 17, 2009
[Improved glucose control and weight loss with exenatide in patients with type 2 diabetes: results of a retrospective observational multicentre Belgian study]C De Block, N Paquot, N Daoudi, et al.
Revue Medicale De Liege|January 9, 2014
[European guidelines for the management of diabetes, prediabeties and cardiovascular disease. First part. Management of diabetes and cardiovascular risk factors]A J Scheen, R P Radermecker, J C Philips, et al.
Diabetologia|November 1, 1989
Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patientsA J Scheen, J Gillet, J Rosenthaler, et al.
Revue Medicale De Liege|May 13, 1999
[How I treat ... an individual with severe obesity and metabolic abnormalities with gastroplasty]F H Luyckx, A J Scheen, M R Letiexhe, et al.
Pageof 60